BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 28514443)

  • 1. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
    Hattori A; Tsunoda M; Konuma T; Kobayashi M; Nagy T; Glushka J; Tayyari F; McSkimming D; Kannan N; Tojo A; Edison AS; Ito T
    Nature; 2017 May; 545(7655):500-504. PubMed ID: 28514443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
    Ito T; Kwon HY; Zimdahl B; Congdon KL; Blum J; Lento WE; Zhao C; Lagoo A; Gerrard G; Foroni L; Goldman J; Goh H; Kim SH; Kim DW; Chuah C; Oehler VG; Radich JP; Jordan CT; Reya T
    Nature; 2010 Aug; 466(7307):765-8. PubMed ID: 20639863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
    Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
    Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain amino acid metabolism in cancer.
    Ananieva EA; Wilkinson AC
    Curr Opin Clin Nutr Metab Care; 2018 Jan; 21(1):64-70. PubMed ID: 29211698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.
    Qian L; Li N; Lu XC; Xu M; Liu Y; Li K; Zhang Y; Hu K; Qi YT; Yao J; Wu YL; Wen W; Huang S; Chen ZJ; Yin M; Lei QY
    Nat Metab; 2023 Jul; 5(7):1159-1173. PubMed ID: 37337119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
    Li H; Ye D; Xie W; Hua F; Yang Y; Wu J; Gu A; Ren Y; Mao K
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCAT1 promotes osteoclast maturation by regulating branched-chain amino acid metabolism.
    Go M; Shin E; Jang SY; Nam M; Hwang GS; Lee SY
    Exp Mol Med; 2022 Jun; 54(6):825-833. PubMed ID: 35760874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukaemia as a model of disease evolution in human cancer.
    Melo JV; Barnes DJ
    Nat Rev Cancer; 2007 Jun; 7(6):441-53. PubMed ID: 17522713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolon formation regulates branched-chain amino acid oxidation and homeostasis.
    Patrick M; Gu Z; Zhang G; Wynn RM; Kaphle P; Cao H; Vu H; Cai F; Gao X; Zhang Y; Chen M; Ni M; Chuang DT; DeBerardinis RJ; Xu J
    Nat Metab; 2022 Dec; 4(12):1775-1791. PubMed ID: 36443523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
    Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.
    Gu Z; Liu Y; Cai F; Patrick M; Zmajkovic J; Cao H; Zhang Y; Tasdogan A; Chen M; Qi L; Liu X; Li K; Lyu J; Dickerson KE; Chen W; Ni M; Merritt ME; Morrison SJ; Skoda RC; DeBerardinis RJ; Xu J
    Cancer Discov; 2019 Sep; 9(9):1228-1247. PubMed ID: 31189531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired expression of BCAT1 relates to muscle atrophy of mouse model of sarcopenia.
    Ouyang H; Gao X; Zhang J
    BMC Musculoskelet Disord; 2022 May; 23(1):450. PubMed ID: 35562710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCAT1 promotes proliferation of endometrial cancer cells through reprogrammed BCAA metabolism.
    Wang P; Wu S; Zeng X; Zhang Y; Zhou Y; Su L; Lin W
    Int J Clin Exp Pathol; 2018; 11(12):5536-5546. PubMed ID: 31949641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCAT1 and BCAT2 disruption in CHO cells has cell line-dependent effects.
    Pereira S; Ley D; Schubert M; Grav LM; Kildegaard HF; Andersen MR
    J Biotechnol; 2019 Dec; 306():24-31. PubMed ID: 31465797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.
    Tönjes M; Barbus S; Park YJ; Wang W; Schlotter M; Lindroth AM; Pleier SV; Bai AHC; Karra D; Piro RM; Felsberg J; Addington A; Lemke D; Weibrecht I; Hovestadt V; Rolli CG; Campos B; Turcan S; Sturm D; Witt H; Chan TA; Herold-Mende C; Kemkemer R; König R; Schmidt K; Hull WE; Pfister SM; Jugold M; Hutson SM; Plass C; Okun JG; Reifenberger G; Lichter P; Radlwimmer B
    Nat Med; 2013 Jul; 19(7):901-908. PubMed ID: 23793099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
    Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
    Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.